SUVRETTA CAPITAL MANAGEMENT LLC
Q4 2025 Form 13-F
NEW YORK, NEW YORK
CIK 0001569064
· CRD 165153
· SEC-registered investment adviser
$4.9B Reported Value Total
MONTANOVA CAPITAL, LLC reports 10 total accounts under management (AUM). There are 10 discretionary accounts valued at $7,866,697,832, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
5 funds
· $7.8B gross asset value
Hedge Fund: $7.8B · Venture Capital Fund: $7.4M
Source: Form ADV filed 2026-07-01
Reported value
$4.9B
Quarter over quarter
+10.4%
Holdings
90
Top-10 concentration
41.9%
Key People
Form ADV owners & control persons
Aaron Leonard Cowen
MANAGING MEMBER
Andrew Jon Nathanson
GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER
Glenn Michael Shepard
CHIEF FINANCIAL OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2025 13F record
Q4 2025 13F filing summary
| Period of report | December 31, 2025 |
|---|---|
| Filed | February 17, 2026 |
| Form | 13F-HR |
| Reported value | $4.9B |
| Positions | 90 |
| Change in reported value | +25.0% |
| New positions | 13 |
| Exited positions | 13 |
| Position turnover | 25.2% |
| Top-10 concentration | 41.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
95 | $5.5B |
|
Q1 2026 13F
Filed May 15, 2026
|
88 | $3.9B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
90 | $4.9B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
90 | $3.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
95 | $3.3B |
|
Q1 2025 13F
Filed May 15, 2025
|
99 | $2.7B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
94 | $2.9B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
96 | $3.1B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
97 | $2.7B |
|
Q1 2024 13F
Filed May 15, 2024
|
99 | $2.7B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
87 | $2.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
87 | $1.9B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
100 | $1.9B |
|
Q1 2023 13F
Filed May 15, 2023
|
92 | $2.4B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
89 | $2.4B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
71 | $2.4B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
89 | $2.6B |
|
Q1 2022 13F
Filed May 16, 2022
|
87 | $3.3B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
94 | $5.2B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
105 | $5.9B |
31 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SPY P SPDR S&P 500 ETF TR | $545.5M | 11.17% |
| 2 | ARQT ARCUTIS BIOTHERAPEUTICS INC | $347.4M | 7.12% |
| 3 | ARKG P ARK ETF TR | $241.7M | 4.95% |
| 4 | BNTC BENITEC BIOPHARMA INC | $155.6M | 3.19% |
| 5 | LEGN LEGEND BIOTECH CORP | $143.7M | 2.94% |
| 6 | EYPT EYEPOINT INC | $143.0M | 2.93% |
| 7 | RCUS ARCUS BIOSCIENCES INC | $123.7M | 2.53% |
| 8 | IMTX IMMATICS N.V | $117.5M | 2.41% |
| 9 | BHVN BIOHAVEN LTD | $116.1M | 2.38% |
| 10 | META META PLATFORMS INC | $111.6M | 2.29% |
| 11 | APLS APELLIS PHARMACEUTICALS INC | $104.0M | 2.13% |
| 12 | NVDA NVIDIA CORPORATION | $99.0M | 2.03% |
| 13 | KO COCA COLA CO | $96.7M | 1.98% |
| 14 | GE GE AEROSPACE | $95.6M | 1.96% |
| 15 | AMZN AMAZON COM INC | $93.7M | 1.92% |
| 16 | PVLA PALVELLA THERAPEUTICS INC NE | $93.4M | 1.91% |
| 17 | KURA KURA ONCOLOGY INC | $89.1M | 1.83% |
| 18 | BAC BANK AMERICA CORP | $83.5M | 1.71% |
| 19 | AMD ADVANCED MICRO DEVICES INC | $83.4M | 1.71% |
| 20 | HIMS P HIMS & HERS HEALTH INC | $83.1M | 1.7% |
Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.